Abstract
| INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a common disease that is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. 1 Although inhalation therapy, anti-inflammatory drugs, theophylline and corticosteroids are typically used to treat COPD, there are still no targeted treatments because of poorly clarified mechanisms. Thus, it is extremely important to understand the pathologic mechanisms of COPD to produce more specific and efficient therapeutic drugs for COPD. The pathogenesis of COPD is rather complicated. Many novel hypotheses, such as deviated microbiota, air pollutants-related damage and abnormal autoimmune process, have been discussed more extensively. Recently, more and more studies have suggested that autoimmune response plays an important role in the pathogenesis of COPD. Immune cells such as lymphocyte, neutrophil and macrophages are significantly increased in the process of COPD. Meanwhile, the presence of anti-elastin antibody and Th1 cell response is associated with the severity of emphysema. 2 T lymphocytes can be affected only when they are stimulated by antigen, and then, the activated T lymphocytes translocate to the inflammatory sites and cause a series of inflammatory reactions. The exposure of elastin from lung tissue is assumed as the antigen to induce T lymphocytes to migrate from peripheral circulation to the specific sites for inflammatory reaction. The antigen-specific "armed" effector T cells can cause various injuries by directing cytopathic effects, producing of diverse pro-inflammatory mediators and cytokines, 3 which may be the initial factor in COPD.
The exposure of antigen can cause sequential events, involving Th1 cells, Th2 cells, CXCR3 and its ligands. The imbalance of the cytokines secreted by Th1 cells and Th2 cells played a key role in this process. Previous studies have demonstrated that T cell activation induced IFN-c expression in the presence or absence of accessory cells in COPD. In COPD patients with respiratory failure, the imbalance of Th1/Th2 was broken, with increased Th2 and decreased Th1. Interestingly, after the treatments, the balance of Th1/ Th2 was improved.
4 Th1-biased immunity has previously been shown to be associated with the immunopathology of COPD and emphysema, but whether respiratory viral infection exacerbates Th1 immunity or evokes an aberrant systemic or lung-specific Th2 response remains unclear. 5 Additionally, CXCR3 expression may play a potential role during primary responses, as it plays important roles in the migratory behaviour and cellular interactions of T cells in the lymphoid compartment. 6 Chemokine receptor CXCR3 regulates immune responses in secondary lymphoid structure and is highly expressed by Th1 lymphocytes in the airway in COPD. 7 The damage from inflammation causes autoantigen released, T cells activated, CD4 + Th1 cells specifically converted and activated, CXCR3 ligand expressed. However, the mechanism of initial inflammation remains unclear.
In this study, we tried to determine the role of Th1/Th2 cytokines in COPD and to confirm the hypothesis that elastin exposure due to long-term smoking served as an antigen to initiate the stimulation of CD4 + Th1-CXCR3 immune inflammation pathway in COPD exacerbation.
| MATERIALS AND METHODS

| Subjects
All subjects were recruited at the First Affiliated Hospital of Xi'an Jiaotong University from 1 April 2016 to 31 December 2016, including 30 acute exacerbation COPD (AECOPD) patients, 15 patients in remission stage, and 15 control subjects without COPD. All COPD patients including the acute exacerbation and remission were diagnosis based on the current GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria that is a post-bronchodilator forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) <70%. GOLD scores were assigned on the basis of pulmonary function criteria. 1 Acute exacerbation COPD group which had a clear diagnosis of COPD showed some exacerbation symptoms of cough, dyspnoea, and sputum production. Acute exacerbation was diagnosed when respiratory symptoms in patients with COPD worsened to the point where medication change was required. The remission stage was judged when the symptoms were alleviated after standard medical treatment for at least 10 days. And the time point was defined according to following items: (1): sputum turning thin and white with significantly less production; (2): body temperature decreases to <37°C, blood leucocyte count is below 10 9 10 9 /L; (3): significant relief of dyspnoea. All COPD subjects had no known comorbidities. The control subjects did not have related diseases of respiratory system. Clinical data including general information, history, smoking history, lung function, image data, and laboratory tests were collected. The characteristics of subjects are listed in Table 1 . Written informed consents were obtained for all involved subjects in accordance with the Institutional Review Board (IRB) of the First Affiliated Hospital of Xi'an Jiaotong University.
| Blood and plasma
Heparinized blood was obtained from subjects by venipuncture, and plasma was isolated by centrifugation.
| Cells isolation
Peripheral blood mononuclear cells (PBMC) were isolated from AECOPD patients' heparinized blood using a density gradient on Ficoll-Paque Plus. Total cell counts of PBMC were performed using a hemocytometer and expressed as the number of cells per millilitre. Then PBMCs were transferred to a T-25 tissue culture flask containing RPMI 1640 medium with 10% FBS (Gibco FBS10099-141, USA) and antibiotics (penicillin 100 IU/mL and streptomycin 100 mg/mL).
The na€ ıve CD4+T cells were isolated from the PBMCs by the magnetic separation kits (MiniMACS na€ ıve CD4 Isolation kit; Miltenyi Biotec GmbH 130094131, Germany) according to the manufacturer's instructions. The isolated cells were then cultured in the same condition as the PMBCs in a 37°C incubator with 5% CO 2 atmosphere.
| The mRNA expression of IL-2, IL-4, IL-13, IFN-c
The PBMCs which were cultured for 3 days were stimulated with elastin (30 ng/mL; Sigma E7152, USA) and collagen human type I (30 ng/mL; Sigma C7624), respectively. The total RNA was extracted by the RNAfast200 Mix (FASTAGEN 220010, China). Then the cDNA was isolated by the reverse-transcription using PrimeScript TM RT Master Mix (TaKaRa RR036A, Japan)
according to manufacturer's recommendation. The mRNA levels of IL-2, IL-4, IL-13 and IFN-c were determined by real-time PCR. GAPDH was used as an internal control. The primers used for each gene and conditions for PCR are detailed in Table 2 . All these primer sequences were kindly provided by the company of Sangon in China. Relative expression levels in stimulated cells were determined using the 2 DDC t method normalizing to the endogenous control. Each was conducted at least 40 cycles and got the melting curve. We repeated every sample at 6 times.
| Flow-based analysis of na€ ıve CD4+T cells
The na€ ıve CD4+T cells were centrifuged at 200 g for 10 minutes at room temperature, and the supernatant was discarded. Then the cells were washed twice with PBS at 4°C, followed by staining with 5 lL of APC anti-human CD4 antibody (Biolegend 317415) and 5 lL FITC anti-human CD45RA antibody (Biolegend 304105), while control staining was performed using isotype-matched and irrelevant antibodies that were also directly conjugated to APC or FITC. The fluorescence intensity of the cells was analysed using a flow cytometry system.
| The activation of na€ ıve CD4+T cells and EILSPOT
The 10 lg/mL of humanized OKT3 anti-CD3 antibody (Sino Biological lnc 10977-H001, China) in Histidine and Arginine buffer was added to each T-25 tissue culture flask and then the cap was tightly closed to avoid evaporation before incubating at 37°C for 2 hours. After rinsing all unbound antibody, 5 mL of the counted cell suspension was added to the flask before adding soluble anti-CD28 (Sino Biological lnc 11524-H001) to cells at the concentration of 2 lg/mL. The cells were incubated for 2 days in order to obtain the activated CD4+T cells. Then we studied antigeninduced CD4 cell-derived ELISPOT spot size distribution in humans. Human IFN-c precoated enzyme-linked immunospot assay (ELISPOT) kit (DKW 22-1000, China) were used to perform the ELISPT assays according to manufacturer's instructions. These cells were divided into 6 groups based on the stimulation conditions, which were PHA, culture medium, elastin peptide (30 ng/mL), elastin peptide (15 ng/mL), collagen peptide (30 ng/mL) and collagen peptide (15 ng/mL). Eventually, data are expressed as Spot Forming units per well. Spot size histograms were created by an embedded software. 
| Statistical methods
Data are expressed as means AE SD. Test of normality was performed by the Kolmogorov-Smirnov test. All data were of nonparametric distribution. As appropriate, comparisons between 2 groups were assessed by t test, and more than 2 groups were carried out by the ANOVA. The diagram was drawn by the GraphPad PRISM 6.0 software. Statistical tests were performed using SPSS 23.0. A value of P < .05 or P < .01 was considered significantly.
3 | RESULTS
| Study patients characteristics, and laboratory tests
A total of 60 individuals were included in this study (AECOPD, n = 30; remission, n = 15; controls, n = 15). Table 1 provides details of their baseline characteristics. We enrolled patients with either the diagnosis of AECOPD or underwent remission after regular treatment, along with control individuals. There were no differences in gender and age among groups (P > .05). The smoking index, the number of smokers, non-smokers, ex-smokers, FEV 1 % predicted, FEV 1 /FVC predicted and BSA (Body Surface Area) were similar between AECOPD groups and remission groups. There were 10 patients in remission stage inhaled Tiotropium and 5 patients inhaled Seretide regularly. The level of C-reactive protein (CRP) and the percentage of neutrophils in COPD patients were significantly higher than that in the control group (P < .01). The concentration of CRP in AECOPD was significantly higher than that in remission group (P < .01).
| The concentrations of IL-2, IL-4, IL-13, IFN-c and CXCR3
The CXCR3 level in the AECOPD was higher than that in the control group (58.06 AE 40.07 pg/mL vs 24.62 AE 6.53 pg/mL, P < .05). It showed no differences in CXCR3 levels among the AECOPD group, remission group and the controls ( Figure 1A ). The concentration of IL-2 in the AECOPD patients (54.60 AE 64.79 pg/mL) and remission period (105.97 AE 82.71 pg/mL) was significantly lower than that in the control group (184.66 AE 74.30 pg/ mL) (P < .01), and AECOPD group was slightly lower than that in remission group (P < .05) ( Figure 1B) . IL-4 levels were significantly increased in AECOPD group when compared with the control (75.46 AE 55.91 pg/mL vs 44.28 AE 18.06 pg/mL, respectively, P < .05). There were no significant differences in IL-4 levels between the AECOPD group and remission group, or between the remission and the controls ( Figure 1C) . In AECOPD group, concentrations of IL-13 were significantly higher than that observed in the control group (10.83 AE 9.80 pg/mL vs 3.08 AE 2.64 pg/mL, P < .05). There were no differences in IL-13 levels between the AECOPD and remission groups, or between remission group and the controls (Figure 1D) . The concentration of IFN-c in COPD patients, included the acute exacerbation (137.31 AE 63.58 pg/mL) and remission period (238.96 AE 199.84 pg/mL), was significantly higher than that in control group (98.46 AE 78.69 pg/mL) (P < .05), while AECOPD group was slightly lower than that remission group (P < .05) ( Figure 1E ). The Th1 cells typically produce IFN-c and IL-2, while the Th2 cells typically produce IL-4 and IL-13. It can be inferred that in acute exacerbation stage, the number of Th1 cells was declined, while in remission, Th1 cells were increased.
| Expression of IFN-c, IL-2, IL-4 and IL-13 mRNA following the specific antigen stimulations
The mRNA levels of IFN-c, IL-2, IL-4 and IL-13 were detected by qRT-PCR. We found that the expression levels of these genes are lower in elastin-stimulated PBMCs than that in collagen-stimulated ones in Figure 2 . Interestingly, the expression levels of IFN-c and IL-2 were higher than that of IL-4 and IL-13 in collagenstimulated PBMCs. However, there were no obvious differences between elastin-stimulated PBMCs and collagen-stimulated ones.
| The secretion of IFN-c by the CD4+Th1 cells stimulated by different antigens
We observed different secretions of IFN-c among the groups, under various stimulation conditions, including 30 ng/mL elastin stimulation, 15 ng/mL elastin stimulation, 30 ng/mL collagen stimulation, 15 ng/mL collagen stimulation, positive stimulation, no stimulation. The secretion spot of 30 ng/mL of elastin antigen was 401 AE 154, which was higher compared to 123 AE 58 (15 ng/mL elastin stimulation), 197 AE 67 (30 ng/mL collagen stimulation), 124 AE 55 (15 ng/mL elastin collagen), and 67 AE 55 (no stimulation). Especially, the CD4+Th1 cells stimulated by elastin antigen, as a specific antigen inducing the secretion of IFN-c, secreted more IFN-c than that by collagen (P < .01) (Figures 3 and 4) .
| DISCUSSIONS
The main findings in this study were as follows: (1) group. **, vs control P < .01, *, vs control P < .05, M, vs remission P < .05
Th2-biased allergic inflammation. 9 Th1 cells evoke cellmediated immunity and phagocyte-dependent inflammation, while Th2 cells evoke strong antibody responses and eosinophil accumulation. Both environmental and genetic factors act in concert to determine the Th1 or Th2 polarization. Th1-dominated response is involved in the pathogenesis of organ-specific autoimmune disorders. Th2-dominated response plays a pathogenic role in both progressive systemic sclerosis and cryptogenic fibrosing alveolitis. 10 Our data demonstrated that the Th1/Th2 cytokines changes between acute exacerbation and remission of COPD. In acute exacerbation stage, the number of Th1 cells was declined, while in remission, Th1 cells were increased. Obviously, the Th1 cells were more sensitive in the immune response. IFN-c is likely to be important in early host defense against infection, whereas T lymphocytes become the major source of IFN-c in the adaptive immune response.
11 IL-2, a pro-inflammatory and strong immunoregulatory Th1 cytokines, affects various immune cells. 12 IL-4 plays a pivotal role in Th2 cell proliferation, cytokines production and IgE synthesis, while IL-13 is important in the pathological features of disease. 13 In this study, the concentration of IFN-c of COPD patients in both the acute exacerbation and remission was significantly higher than that in control group, and AECOPD group was slightly lower than in remission group. The concentration of IL-2 in COPD patients in both acute exacerbation and remission was significantly lower than that in control group, and the AECOPD group was slightly lower than that in the remission. The concentration of IL-4 and IL-13 in AECOPD group was higher than that in the control group. It is obvious that no significant differences were detected in the secretion of IL-3 and IL-13 between the AECOPD and remission, and the secretion of IFN-c and IL-2 showed differences between AECOPD and remission. In the acute exacerbation stage, the symptoms reflected a flare-up extensive inflammatory processes. 14 The link among AECOPD, airway alternation and systemic inflammation has been well established. 15 Respiratory infections are associated with the majority of COPD exacerbations and their severity, especially for those with viral/ bacterial coinfection. 16 In the AECOPD patients' airway, a large number of pathogen-specific antibodies can be found, indicating the activity of immune reaction. 17 Because of the immune response, the level of Th1 was reduced, but the level of Th2 occupied dominant position in delayed allergy. Oppositely, the level of Th2 cells in remission was decreased because of the treatment, while Th1 cells were increased in cellular immunity. CXCR3 is a chemokine receptor that is rapidly induced on naive T cells following activation, and preferentially it remains highly expressed in Th1-CD4+T cells. 18 The recruitment of leucocytes to infection foci depends strongly on the local release of chemoattractant mediators. CXCR3 is an important node in the chemokine signalling network and is expressed by multiple leucocyte lineages, including T cells and macrophages. 19 We have found that in the COPD patients with acute aggravating period, CXCR3 in peripheral blood was increased compared with the control group. The CXCR3 dependent amplification loop between IFN-c expressing T cells and the cells expressing the IFNc inducible ligands may be important in induction of T cells. We reasoned that elastin exposure due to long-term smoking might serve as an antigen to initiate the stimulation of CD4 + Th1-CXCR3 immune inflammation pathway in COPD patients. Elastin is a key extracellular matrix protein which is critical to the elasticity and resilience of many vertebrate tissues including large arteries, lung, ligament, tendon, skin, and elastic cartilage. 20 The hypothesis was that destruction of lung elastin, which occurs in pulmonary emphysema, may be associated with lung injury induced by intratracheal injection of proteolytic enzymes. 21 The present study showed that the elastin mRNA expression was increased significantly in very severe COPDs, and the upregulation of elastin expression was correlated with the severity of airway limitation. 22 Slowik et al 23 found
that a tissue matrix effect of elastin degradation from second-hand smoke exposure and possible lung structure injury may result in COPD. To confirm elastin as an antigen, we used different doses of elastin and collagens to stimulate the na€ ıve CD4+T cells from exacerbation COPD patients to determine the specificity of elastin in stimulating cytokines secretion in autoreactive T cells development. In response to elastin peptides, but not collagen, T cells from individuals with emphysema released much higher IFN-c. In summary, the CXCR3 was highly expressed in the plasma of COPD patients; however, there were different Th1/Th2 dominant states in different stages of disease. We found that Th2 cells were dominated in AECOPD, while Th1 cells were dominated in remission group. Our data strongly indicated that elastin exposure was an inducing factor in the inflammatory response of COPD. The damage from inflammation caused autoantigen released, T cells activated, CD4 + Th1 cells specifically converted and activated, CXCR3 À ligand expression. The CD4+Th1-specific conversion and activation may be an initiator of COPD immune inflammatory response. These findings provide basis for further investigations on the mechanisms of COPD.
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